ArQule Presents Phase 1/2 Data for Patients With Intrahepatic Cholangi

Discussion Board › Forums › Clinical Trials › ArQule Presents Phase 1/2 Data for Patients With Intrahepatic Cholangi

Viewing 7 posts - 1 through 7 (of 7 total)
  • Author
    Posts
  • July 6, 2017 at 2:21 am #94700
    marions
    Moderator

    Arapro….fantastic, you appear to handle your treatments in the most incredible way. Keep it going.

    Hugs
    Marion

    July 6, 2017 at 12:23 am #94699
    arapro
    Spectator

    Hi, sorry it’s been a while Marion.

    Irinotecan was pretty manageable actually. Tomorrow I start with gem/cis again.

    Will let you know :)

    I feel great btw. It’s bizarre

    June 22, 2017 at 8:05 pm #94698
    marions
    Moderator

    Arapro….of course, a tidal wave of good wishes is heading your way.
    Irinotecan is pretty harsh on the system, are you handling the current chemo better?

    Hugs
    Marion

    June 21, 2017 at 10:26 pm #94697
    arapro
    Spectator

    Hello Everyone !

    I have that mutation as well, the FGFR2. Went for a scan on monday and they found new multiple lesions on my peritoneal cavity. They stopped the Irinotecan. They did filled my pump with FUDR. Now in a couple of weeks they want to go in that trial for ARQ087.

    Wish me luck !

    Alejandro Reyes
    reyesalejandro.com

    June 7, 2017 at 10:55 pm #94696
    marions
    Moderator

    Julie….always happy to hear from you.
    Hugs
    Marion

    June 7, 2017 at 10:15 pm #94695
    iowagirl
    Member

    Thank you, Marion. This is one of my mutations and one for someone else I know. I’ll share the info with her. Julie

    June 7, 2017 at 8:30 pm #13248
    marions
    Moderator

    http://checkrare.com/asco-news-arqule-presents-phase-12-data-patients-intrahepatic-cholangiocarcinoma/

  • Author
    Posts
Viewing 7 posts - 1 through 7 (of 7 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.